. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » CabergolineDopamine Agonists/pharmacologyDopamine Agonists/therapeutic useErgolines/pharmacologyErgolines/therapeutic useErgot Alkaloids/pharmacologyErgot Alkaloids/therapeutic useHumansParkinson Disease/drug therapy
Substances: See more » Dopamine AgonistsErgolinesErgot AlkaloidsCabergoline
Year: 2002 PMID: 12211142 DOI: 10.1002/mds.5563
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338